Cargando…

Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward

Pharmacopeia is the national collection of quality standards of pharmaceutical products. It is an important instrument for drug safety. The inclusion of radiopharmaceuticals (RPs) in the Indian Pharmacopeia is a step-in right direction as the adaptation of provision of pharmacopeia will reduce the u...

Descripción completa

Detalles Bibliográficos
Autor principal: Meher, Bikash Ranjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958968/
https://www.ncbi.nlm.nih.gov/pubmed/31949360
http://dx.doi.org/10.4103/ijnm.IJNM_133_19
_version_ 1783487507940245504
author Meher, Bikash Ranjan
author_facet Meher, Bikash Ranjan
author_sort Meher, Bikash Ranjan
collection PubMed
description Pharmacopeia is the national collection of quality standards of pharmaceutical products. It is an important instrument for drug safety. The inclusion of radiopharmaceuticals (RPs) in the Indian Pharmacopeia is a step-in right direction as the adaptation of provision of pharmacopeia will reduce the unwanted adverse effects and ensure the effectiveness of RPs.
format Online
Article
Text
id pubmed-6958968
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-69589682020-01-16 Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward Meher, Bikash Ranjan Indian J Nucl Med Commentary Pharmacopeia is the national collection of quality standards of pharmaceutical products. It is an important instrument for drug safety. The inclusion of radiopharmaceuticals (RPs) in the Indian Pharmacopeia is a step-in right direction as the adaptation of provision of pharmacopeia will reduce the unwanted adverse effects and ensure the effectiveness of RPs. Wolters Kluwer - Medknow 2020 2019-12-31 /pmc/articles/PMC6958968/ /pubmed/31949360 http://dx.doi.org/10.4103/ijnm.IJNM_133_19 Text en Copyright: © 2019 Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Commentary
Meher, Bikash Ranjan
Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward
title Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward
title_full Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward
title_fullStr Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward
title_full_unstemmed Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward
title_short Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward
title_sort inclusion of radiopharmaceuticals in the indian pharmacopeia: a step forward
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958968/
https://www.ncbi.nlm.nih.gov/pubmed/31949360
http://dx.doi.org/10.4103/ijnm.IJNM_133_19
work_keys_str_mv AT meherbikashranjan inclusionofradiopharmaceuticalsintheindianpharmacopeiaastepforward